Drawing for ADVATIS

USPTO serial 79171523

ADVATIS

Reviewed by CopyMark Law Group

Reg. 4916196Status 404
Filing date
Status date
Registration date
Mar 15, 2016
Examiner
JACKSON, WILLIAM D
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ADVATIS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
010Medical specimen bags for the sampling and the conservation of organic and biological materials, namely, stem cells, bones, heart valves and skinSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Dec 11, 2025DETHDEATH OF INTERNATIONAL REGISTRATION—
Jul 25, 2023INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Jun 30, 2023INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jun 30, 2023INPCINVALIDATION PROCESSED—
May 30, 2023INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
May 27, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 14, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 30, 2022C71TCANCELLED SECTION 71—
Apr 1, 2022NREPNEW REPRESENTATIVE AT IB RECEIVED—
Oct 27, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jul 17, 2021NREPNEW REPRESENTATIVE AT IB RECEIVED—
May 21, 2021CHLDCHANGE OF OWNER RECEIVED FROM IB—
Dec 23, 2016FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 1, 2016XXSSGENERIC MADRID TRANSACTION SENT TO IB—
Jul 1, 2016XXCRGENERIC MADRID TRANSACTION CREATED—
Jun 15, 2016FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Mar 15, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 4, 2016GPNXNOTIFICATION PROCESSED BY IB—
Dec 29, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Dec 16, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Dec 9, 2015NPUBNOTICE OF PUBLICATION—
Nov 13, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 13, 2015TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 13, 2015CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 13, 2015TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 25, 2015RFNTREFUSAL PROCESSED BY IB—
Sep 9, 2015RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Sep 9, 2015RFRRREFUSAL PROCESSED BY MPU—
Sep 9, 2015RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Sep 8, 2015CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 8, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Sep 3, 2015DOCKASSIGNED TO EXAMINER—
Sep 3, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Aug 27, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance